Bio-Key International (BKYI) closed at $2.09 on November 16, 2026, down 1.4% from the previous close, on volume of 26,736 shares (30-day average 5,785,334).
Data as of November 16, 2026.
Bio-Key International Earnings Call Signals Growth
TipRanks (Sun, 15-Nov 12:21 AM ET)
Seeking Alpha News (Fri, 13-Nov 8:03 AM ET)
Globe Newswire (Fri, 13-Nov 7:59 AM ET)
Here are the major earnings before the open Friday
Seeking Alpha News (Thu, 12-Nov 6:00 PM ET)
BIO-key Enters Gaming / Hospitality Market with Contract from Major U.S. Casino Resort
Globe Newswire (Wed, 11-Nov 8:27 AM ET)
Globe Newswire (Fri, 6-Nov 3:36 PM ET)
Globe Newswire (Tue, 3-Nov 4:00 AM ET)
Globe Newswire (Wed, 28-Oct 4:00 AM ET)
BIO-key rallies after a new Middle East government adopts PortalGuard and FIDO2 Passkey:YOU
Market Chameleon (Fri, 23-Oct 5:53 AM ET)
Globe Newswire (Thu, 22-Oct 3:59 AM ET)
BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
Bio-Key International trades on the NASDAQ stock market under the symbol BKYI.
As of November 16, 2026, BKYI stock price declined to $2.09 with 26,736 million shares trading.
BKYI has a beta of -4.37, meaning it tends to be less sensitive to market movements. BKYI has a correlation of 0.13 to the broad based SPY ETF.
BKYI has a market cap of $4.25 million. This is considered a Sub-Micro Cap stock.
Last quarter Bio-Key International reported $1 million in Revenue and -$4.01 earnings per share. This fell short of revenue expectation by $-920,000 and missed earnings estimates by -$3.66.
BKYI support price is $1.87 and resistance is $2.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BKYI shares will trade within this expected range on the day.